[1] |
KAUR S, KAUR S. Recent advances in vaginal delivery for the treatment of vulvovaginal candidiasis[J]. Curr Mol Pharmacol, 2021, 14(3):281-291.
|
[2] |
焦黎旭, 王莹莹, 潘娜. 乳酸菌阴道胶囊联合硝呋太尔制霉素阴道软胶囊在念珠菌性阴道炎中的应用价值[J]. 实用中西医结合临床, 2022, 22(14):32-35.
|
[3] |
杨利林, 郜洁, 丘维钰, 等. 基于中医传承辅助平台的念珠菌性阴道炎外用治疗方剂组方规律分析[J]. 时珍国医国药, 2018, 29(5):1251-1253.
|
[4] |
樊尚荣, 黎婷. 2015年美国疾病控制中心阴道感染诊断和治疗指南[J]. 中国全科医学, 2015(25):3046-3049.
DOI
|
[5] |
孙康德, 张家胜, 陈旭, 等. 口腔白念珠菌耐药性及毒力因子表达水平相关性研究[J]. 检验医学, 2019, 34(8):730-735.
DOI
|
[6] |
AKIMOTO-GUNTHER L, BONFIM-MENDONÇA PDE S, TAKAHACHI G, et al. Highlights regarding host predisposing factors to recurrent vulvovaginal candidiasis:chronic stress and reduced antioxidant capacity[J]. PLoS One, 2016, 11(7):e0158870.
|
[7] |
LOHSE M B, GULATI M, JOHNSON A D, et al. Development and regulation of single- and multi-species Candida albicans biofilms[J]. Nat Rev Microbiol, 2018, 16(1):19-31.
|
[8] |
WALL G, MONTELONGO-JAUREGUI D, VIDAL BONIFACIO B, et al. Candida albicans biofilm growth and dispersal:contributions to pathogenesis[J]. Curr Opin Microbiol, 2019,52:1-6.
|
[9] |
RAJENDRAN R, SHERRY L, NILE C J, et al. Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection-Scotland,2012-2013[J]. Clin Microbiol Infect, 2016, 22(1):87-93.
|
[10] |
MAJUMDAR T, MULLICK J, BIR R, et al. Determination of virulence factors and biofilm formation among isolates of vulvovaginal candidiasis[J]. J Med Sci, 2016, 36(2):53-58.
|
[11] |
李焕荣, 王慧慧, 李佳, 等. 复发性细菌性阴道病生物膜的研究进展[J]. 实用妇产科杂志, 2020, 36(5):358-361.
|
[12] |
汪天明, 马克龙, 吴大强, 等. 中药抗白念珠菌研究新进展[J]. 微生物学报, 2022, 62(11):4273-4286.
|
[13] |
BELMADANI A, SEMLALI A, ROUABHIA M. Dermaseptin-S1 decreases Candida albicans growth,biofilm formation and the expression of hyphal wall protein 1 and aspartic protease genes[J]. J Appl Microbiol, 2018, 125(1):72-83.
|
[14] |
董先红, 程惠芬. 念珠菌感染性阴道炎的病原菌药物敏感性及免疫功能变化[J]. 健康研究, 2019, 39(1):98-101.
|